Opsens (TSX:OPS) FCF Margin % : -15.31% (As of Aug. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Opsens FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Opsens's Free Cash Flow for the three months ended in Aug. 2023 was C$-2.17 Mil. Opsens's Revenue for the three months ended in Aug. 2023 was C$14.19 Mil. Therefore, Opsens's FCF Margin % for the quarter that ended in Aug. 2023 was -15.31%.

As of today, Opsens's current FCF Yield % is -5.07%.

The historical rank and industry rank for Opsens's FCF Margin % or its related term are showing as below:

TSX:OPS' s FCF Margin % Range Over the Past 10 Years
Min: -132.39 Med: -21.34 Max: 5.23
Current: -35.17

During the past 13 years, the highest FCF Margin % of Opsens was 5.23%. The lowest was -132.39%. And the median was -21.34%.

TSX:OPS's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -7.38 vs TSX:OPS: -35.17

Opsens FCF Margin % Historical Data

The historical data trend for Opsens's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens FCF Margin % Chart

Opsens Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

FCF Margin %

Get a 7-Day Free Trial

-7.48

-9.83

5.23

-28.28

-35.17

Opsens Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
FCF Margin %	Get a 7-Day Free Trial															-48.56	-60.97	-54.88	-20.41	-15.31

Competitive Comparison of Opsens's FCF Margin %

For the Medical Instruments & Supplies subindustry, Opsens's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opsens's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Opsens's FCF Margin % falls into.

Opsens FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Opsens's FCF Margin for the fiscal year that ended in Aug. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Aug. 2023 )	/	Revenue (A: Aug. 2023 )
	=	-17.004	/	48.347
	=	-35.17 %

Opsens's FCF Margin for the quarter that ended in Aug. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Aug. 2023 )	/	Revenue (Q: Aug. 2023 )
	=	-2.173	/	14.19
	=	-15.31 %

Opsens FCF Margin % Related Terms

Thank you for viewing the detailed overview of Opsens's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines